Broadly cross-reactive, neutralizing human monoclonal antibodies, including 2F5, 2G12, 4E10 and IgG1 b12, can inhibit HIV-1 infection in vitro at very low concentrations. We examined the ability of these antibodies to inhibit cell-cell fusion between Clone69TRevEnv cells induced to express the viral envelope proteins, gp120/gp41 (Env), and highly CD4-positive SupT1 cells. The cells were loaded with green and red-orange cytoplasmic fluorophores, and fusion was monitored by fluorescence microscopy.status: publishe
We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtid...
ABSTRACT: HIV-1 envelope glycoprotein-mediated fusion is driven by the concerted coalescence of the ...
Pretreatment of HeLa T4 cells with recombinant alpha, beta, or gamma interferon (IFN) was found to s...
Objectives: HIV-1 initiates infection by fusing with CD4+ lymphocytes or macrophages, mediated by th...
Objectives: HIV-1 initiates infection by fusing with CD4+ lymphocytes or macrophages, mediated by th...
Objective: An effective HIV vaccine must be able to block infection by a wide range of viral isolate...
Objective: An effective HIV vaccine must be able to block infection by a wide range of viral isolate...
HIV-1 infects host cells by fusion at the plasma membrane, mediated by the envelope glycoprotein gp1...
<div><p>We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of en...
Abstract During natural HIV infection, an array of host receptors are thought to influence virus att...
Human Immunodeficiency Virus-1 (HIV-1) entry is dependent on the envelope glycoprotein (Env) that is...
We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtid...
We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtid...
We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtid...
(A) Confocal micrographs of CHO-DSP1 cells expressing HIV-1HXB2 Env and HeLa.CD4-DSP2 cells at 24 ho...
We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtid...
ABSTRACT: HIV-1 envelope glycoprotein-mediated fusion is driven by the concerted coalescence of the ...
Pretreatment of HeLa T4 cells with recombinant alpha, beta, or gamma interferon (IFN) was found to s...
Objectives: HIV-1 initiates infection by fusing with CD4+ lymphocytes or macrophages, mediated by th...
Objectives: HIV-1 initiates infection by fusing with CD4+ lymphocytes or macrophages, mediated by th...
Objective: An effective HIV vaccine must be able to block infection by a wide range of viral isolate...
Objective: An effective HIV vaccine must be able to block infection by a wide range of viral isolate...
HIV-1 infects host cells by fusion at the plasma membrane, mediated by the envelope glycoprotein gp1...
<div><p>We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of en...
Abstract During natural HIV infection, an array of host receptors are thought to influence virus att...
Human Immunodeficiency Virus-1 (HIV-1) entry is dependent on the envelope glycoprotein (Env) that is...
We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtid...
We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtid...
We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtid...
(A) Confocal micrographs of CHO-DSP1 cells expressing HIV-1HXB2 Env and HeLa.CD4-DSP2 cells at 24 ho...
We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtid...
ABSTRACT: HIV-1 envelope glycoprotein-mediated fusion is driven by the concerted coalescence of the ...
Pretreatment of HeLa T4 cells with recombinant alpha, beta, or gamma interferon (IFN) was found to s...